Xingfeng Qiu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 1
- Protease and Inhibitor Mechanisms 1
-
- Ubiquitin and proteasome pathways 3
- Biochemical and Molecular Research 2
- Epigenetics and DNA Methylation 1
- Co-authors
- Jiahuai Han (2 shared papers)Yuekun Zhu (6 shared papers)Xuehui Hong (7 shared papers)Yingying Zhang (1 shared paper)Mengya Zhong (6 shared papers)Hengxiao Ni (1 shared paper)Yaoji Liang (1 shared paper)Jin Hu (1 shared paper)
- Journals
- Oncogene (2 papers)Cell Death and Differentiation (2 papers)Oncotarget (1 paper)International Journal of Biological Sciences (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xingfeng Qiu
26 papers receiving 871 citations
Xingfeng Qiu's Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 124
- Molecular Biology 420
- Oncology 96
- Immunology 71
- Hepatology 26
Countries citing papers authored by Xingfeng Qiu
This map shows the geographic impact of Xingfeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfeng Qiu more than expected).
Fields of papers citing papers by Xingfeng Qiu
This network shows the impact of papers produced by Xingfeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfeng Qiu. The network helps show where Xingfeng Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingfeng Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut stem cell necroptosis by genome instability triggers bowel inflammation Hit paper breakdown → | 2020 | 250 |
| 2 | 2019 | 100 | |
| 3 | 2017 | 64 | |
| 4 | 2019 | 62 | |
| 5 | 2018 | 56 | |
| 6 | 2016 | 40 | |
| 7 | 2018 | 40 | |
| 8 | 2019 | 38 | |
| 9 | 2020 | 38 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 30 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2025 | 20 | |
| 15 | 2019 | 15 | |
| 16 | 2016 | 10 | |
| 17 | 2016 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2025 | 4 | |
| 20 | 2018 | 3 |
About Xingfeng Qiu
Xingfeng Qiu is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 26 papers that have together received 883 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Ubiquitin and proteasome pathways (3 papers), MicroRNA in disease regulation (2 papers), Minimally Invasive Surgical Techniques (2 papers), Biochemical and Molecular Research (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Epigenetics and DNA Methylation (1 paper) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Cancer Research (124 citations), Molecular Biology (420 citations), Oncology (96 citations), Immunology (71 citations) and Hepatology (26 citations). Xingfeng Qiu has collaborated with scholars based in China and United States. Frequent co-authors include Jiahuai Han, Yuekun Zhu, Xuehui Hong, Yingying Zhang, Mengya Zhong, Hengxiao Ni, Yaoji Liang, Jin Hu, Wei Mo and Zhang‐Hua Yang. Their work appears in journals such as Oncogene, Cell Death and Differentiation, Oncotarget, International Journal of Biological Sciences and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.